Polycystic ovary syndrome (PCOS) is a common endocrinopathy among female adolescents and young women. The aim of this study was to investigate the relationship between serum 25-hydroxy vitamin D (25[OH] D) levels and metabolic parameters and other characteristics of PCOS and non-PCOS adolescents.
Setting and Participants
We analyzed 31 girls with PCOS as defined using the Rotterdam criteria and 35 girls were non-PCOS control participants.
Interventions and Main Outcome Measures
The serum 25(OH) D level was measured. Anthropometric, clinical, endocrine, and metabolic components were determined in both groups.
The group with PCOS showed no difference in the level of serum 25(OH) D (14.58 ± 6.15 vs 16.02 ± 7.87; P = .414). In addition to this, no significant correlations were found between serum 25(OH) D levels and endocrine or metabolic parameters in either PCOS patients or control participants.
There was no difference in the level of serum 25(OH) D between PCOS patients and matched control participants. Vitamin D deficiency was common among the patients as well as in the control participants. Also, we did not find any relationship between serum 25(OH) D levels and clinical or metabolic profiles in the 2 groups.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Pediatric and Adolescent Gynecology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.Hum Reprod. 2010; 25: 544-51
- Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.J Clin Endocrinol Metab. 1986; 62: 840-848
- Does vitamin D status correlate with clinical and biochemical features of polycystic ovary syndrome in high school girls?.Caspian J Intern Med. 2014; 5: 202-208
- Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at 18 years.Hum Reprod. 2004; 19: 383-392
- Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche.Clin Endocrinol (Oxf). 2000; 53: 523-527
- Obesity and vitamin D deficiency: a systematic review and meta-analysis.Obes Rev. 2015; 16: 341-349
- Vitamin D status and cardiometabolic risk factors in the United States adolescent population.Pediatrics. 2009; 124: 371-379
- Associations between abdominal fat and body mass index on vitamin D status in a group of Spanish schoolchildren.Eur J Clin Nutr. 2010; 64: 461-467
- Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables.J Endocrinol Invest. 2007; 30: 653-658
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil Steril. 2004; 81: 19-25
- Clinical gynecologic endocrinology and infertility. 8th ed. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia (PA)2011: 533-565
- The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women.Diabet Med. 2013; 30: 436-442
- Optimal vitamin D status: a critical analysis on the basis of evidence–based medicine.Clin Endocrinol Metab. 2013; 98: 1283-1304
- Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents.Pediatrics. 2005; 115: e500-e503
- Changes in the atherogenic risk factor profile according to degree of weight loss.Arch Dis Child. 2004; 89: 419-422
- Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy.Nutr Metab Cardiovasc Dis. 2006; 16: 279-284
- Premature adrenarche: findings in prepubertal African-American and Caribbean-Hispanic girls.Acta Paediatr Suppl. 1999; 88: 67-72
- Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.Metabolism. 2011; 60: 1475-1481
- Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.Clin Chem. 2005; 51: 1691-1697
- Vitamin D deficiency in women with polycystic ovary syndrome.Clin Exp Reprod Med. 2014; 41: 80-85
- Vitamin D associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.Eur J Endocrinol. 2011; 164: 741-749
- Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome.Fertil Steril. 2010; 93: 1208-1214
- Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis.Nutrients. 2015; 7: 4555-4577
- Effect of Vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: a meta-analysis.J Obstet Gynaecol Res. 2015; 41: 1791-1802
- Worldwide status of vitamin D nutrition.J Steroid Biochem Mol Biol. 2010; 121: 297-300
- Obesity, related diseases and their relationship with vitamin D deficiency in adolescents.Nutr Hosp. 2016; 33: 856-864
- Vitamin D deficiency.N Engl J Med. 2007; 357: 266-281
- Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod Update. 2010; 16: 347-363
- Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.Exp Clin Endocrinol Diabetes. 2006; 114: 577-583
Published online: August 03, 2017
The authors indicate no conflicts of interest.
© 2017 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc.